Biopsychosocial factors in lymphedema: a longitudinal approach on disease progression and mortality

• Conditions: I89.0; Lymphoedema, not elsewhere classified

• Registration Number: DRKS00024450
• Lead Sponsor: Karl-Franzens-Universität Graz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-08
• Study Completion: 2021-12-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 312

Inclusion Criteria

Participating in the data collection 2002-2006

Exclusion Criteria

Not participating in the data collection 2002-2006

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality: assessed through the Central Person Register<br><br>Edema volume: Kuhnke measurement in the Lymph Clinic Wolfsberg<br><br>Quality of life: Psy-BaDo; Heuft & Senf, 1998

Secondary Outcome Measures

Name	Time	Method
somatic (Giessen Complaints Questionnaire; Brähler & Scheer, 1995) and psychological wellbeing (Symptom Checklist-90-R; Derogatis, 1977), quality of life (Psy-BaDo; Heuft & Senf, 1998), sense of coherence (Sense-of-Coherence-29; Antonovsky, 1983), resilience (Resilience Scale-11; Wagnild & Young, 1993), stressful life events (Social Readjustment Rating Scale; Holmes & Rahe, 1967), and coping flexibility (Coping Flexibility Scale; Kato, 2012).